627101-dc345152-c4d7-4035-8c65-98e75469cff4
Position
Managing Director, Genetic Medicines
Company
SVB Leerink
Location
New York New York UNITED STATES
Bio
Mani Foroohar, M.D. is a Senior Research Analyst within our Therapeutics team focusing on Genetic Medicines. Dr. Foroohar joins SVB Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on US and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors. Prior to Aptigon, Dr. Foroohar was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays. In 2013 Dr. Foroohar co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making. Dr. Foroohar holds an M.D. from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, MBA from Columbia, and a B.S. from UCLA.
Interests
None yet.